SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksVictrex Regulatory News (VCT)

Share Price Information for Victrex (VCT)

Share Price is delayed by 15 minutes
Get Live Data
620.00    9.00 (1.47%)
Bid:
621.00
Ask:
623.00
Spread: 2.00 (0.322%)
Market Cap: £540.17m
VCT Live PriceLast checked at - London Stock Exchange

Intraday Victrex Share Chart

Directorate Change

19 Apr 2017 07:57

RNS Number : 6907C
Victrex PLC
19 April 2017
 
 

 

 

19 April 2017

Victrex plc

Directorate change

David Hummel to retire as Chief Executive

Jakob Sigurdsson appointed as Chief Executive designate

Victrex plc, an innovative world leader in high performance polymer solutions, today announces that David Hummel has notified the Board of his intention to retire after 24 highly successful years as Chief Executive. The Board is pleased to announce that Jakob Sigurdsson, the former Chief Executive of global polymer manufacturer Promens, who has more than 20 years' experience in diverse multinational companies, will join the Company on 1 September 2017 as Chief Executive-designate, following an extensive search process.

Dave, 59, will retire from the Company on 31 March 2018. He will step down as Chief Executive on 30 September 2017, but to enable an orderly transition he will remain on the Board as an Executive Director, reporting to the Chairman, until Victrex's AGM in February 2018. Jakob will succeed Dave as Chief Executive and join the Board on 1 October 2017.

Under Dave's leadership, Victrex has delivered significant shareholder value. Revenue increased from £31 million in 1995 to over £250 million in 2016, with earnings per share growing at more than 10% CAGR.

Larry Pentz, Chairman of Victrex, said: "Dave has been instrumental in Victrex's success. As Chief Executive for nearly 25 years, he has delivered strong growth, helped us to create new markets, innovate into new applications and led a clear and differentiated strategy. We owe significant thanks to Dave for his immense contribution to Victrex and whilst he will remain on the Board until our 2018 AGM, we wish him well in his eventual retirement."

Jakob Sigurdsson, 53, has more than 20 years' experience in large multinational companies, both listed and private, including with Rohm & Haas (acquired by Dow Chemical) in the US, as Chief Executive of food manufacturer Alfesca in Europe, and as Chief Executive of Promens. His roles have spanned marketing, supply chain, business development, strategy and M&A, with particular emphasis on growth in new or developing markets, both within Rohm & Haas and as a CEO and non-executive director.

During his four year tenure as Chief Executive of Promens between 2011 and 2015, he accelerated the Group's growth strategy in both mature and emerging markets, including Pharmaceutical, Chemical and Automotive, leveraging relationships with key global customers. An IPO was initiated in 2014, following the business returning to profitability, prior to a trade sale to RPC Group. Jakob is currently Chief Executive of VIS, the largest Icelandic insurance and re-insurance company, which is listed on the Icelandic stock exchange.

Larry Pentz added: "I am delighted that Jakob will be joining us as our new Chief Executive. He was the standout candidate for the role and has proven experience in delivering focused growth strategies, particularly for new and emerging markets, or new technologies.

"As we communicated at our recent Capital Markets Day, our Polymer & Parts strategy provides a strong platform for growth and the focus is all about execution. Consequently, with Jakob's track record of making markets and delivering growth, as well as his diverse experience in both private and listed companies, the Board believes this appointment is a strong fit with Victrex and will serve us well."

Jakob Sigurdsson commented: "'I am proud and excited to be appointed Chief Executive of such a highly regarded global company. I look forward to working with the Board and the management team to deliver our strategic priorities and execute on our growth opportunities over the coming years."

 

Dave Hummel added: "It has been a privilege to serve Victrex for so many years. I am transitioning from the Company at a time where it is very well positioned for the next phase of growth, with a clear and differentiated strategy, a highly capable management team and a strong pipeline of opportunities. I have every confidence in Jakob and believe that his diverse experience, his passion and curiosity, financial competence and capability will continue to drive the business forward. "

 

There are no disclosures under paragraph 9.6.13R (1)-(6) of the Listing Rules.

 

This announcement contains inside information.

 

Notes:

Jakob Sigurdsson, 53, is an Icelandic national, married with three children. He holds an MBA from Northwestern University in the US, and a BSc in Chemistry from the University of Iceland. His early career was spent in Iceland at a number of manufacturing businesses, including in paint coatings, before joining Rohm & Haas (prior to it becoming part of Dow Chemical) in 1995 within their marketing function.

 

He progressed through several roles at Rohm & Haas, both in Europe and the US, including as General Manager for the Emulsion business in Europe, prior to the acquisition by Dow in 2009. His role as CEO of Alfesca, a food manufacturer in Europe, included acquiring a competitor and divestments of non-core assets. During his role as Chief Executive of Promens between 2011 and 2015, he accelerated the Group's growth strategy in several mature and emerging markets, including Pharmaceutical, Chemical and Automotive markets.

 

Since 2015, Jakob has held a number of non-executive roles in Iceland. He is currently Chief Executive of VIS, the largest Icelandic insurance and re-insurance company, which is listed on the Icelandic stock exchange. Mr Sigurdsson's base salary will be £500,000 and he will participate in the company's bonus and long-term incentive arrangements in accordance with the company's remuneration policy. His notice period of 12 months is in line with other Executive directors. He will relocate to the UK as part of his appointment.

 

Enquiries:

Victrex plc:

Andrew Hanson, Head of Investor Relations & Communications +44 (0) 1253 898121

Larry Pentz, Chairman +44 (0) 1253 898150

David Hummel, Chief Executive +44 (0) 1253 898150

Louisa Burdett, Group Finance Director +44 (0) 1253 898150

 

Teneo Blue Rubicon:

Charles Armitstead +44 (0) 7703 330269

 

About Victrex:

Victrex is an innovative world leader in high performance polymer solutions, focused on the strategic markets of Automotive, Aerospace, Energy, Electronics and Medical. Every day, millions of people rely on products or applications which contain our materials, from smartphones, aeroplanes and cars to oil & gas operations and medical devices. With over 35 years' experience, we are moving beyond the polymer into semi-finished and finished products ('parts') which shape future performance for our customers and our markets, and drive value for our shareholders. Find out more at www.victrexplc.com

 

 

 

Analyst and investor call:

A conference call for analysts and investors will be held this morning at 09.00am BST, hosted by Victrex Chairman Larry Pentz. Dial in details: +44 (0) 203 139 4830, participant passcode 61240146#

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
BOAEAKLNFSSXEEF
Date   Source Headline
29th May 202611:00 amRNSTotal Voting Rights
18th May 20268:50 amRNSDirectorate change
11th May 20267:00 amRNSHalf-year Financial Report
30th Apr 202610:46 amRNSTotal Voting Rights
29th Apr 20264:28 pmRNSHolding(s) in Company
31st Mar 20261:37 pmRNSTotal Voting Rights
24th Mar 20264:29 pmRNSHolding(s) in Company
24th Mar 20262:03 pmRNSHolding(s) in Company
20th Mar 20269:38 amRNSHolding(s) in Company
27th Feb 20262:40 pmRNSTotal Voting Rights
27th Feb 20261:02 pmRNSHolding(s) in Company
24th Feb 202611:41 amRNSHolding(s) in Company
17th Feb 20263:06 pmRNSDirector/PDMR Shareholding
12th Feb 20263:26 pmRNSDirector/PDMR Shareholding
12th Feb 20263:22 pmRNSDirector/PDMR Shareholding
10th Feb 20262:43 pmRNSDirector/PDMR Shareholding
10th Feb 20269:00 amRNSDirectorate change
6th Feb 20261:33 pmRNSResult of AGM
6th Feb 20267:00 amRNSQ1 Trading Update
30th Jan 202611:49 amRNSTotal Voting Rights
28th Jan 202612:25 pmRNSHolding(s) in Company
22nd Jan 202610:21 amRNSHolding(s) in Company
20th Jan 20261:26 pmRNSAdditional Listing
31st Dec 20259:00 amRNSTotal Voting Rights
31st Dec 20259:00 amRNSTotal Voting Rights
22nd Dec 202512:00 pmRNSAnnual Financial Report
22nd Dec 202512:00 pmRNSAnnual Financial Report
18th Dec 202511:49 amRNSDirector/PDMR Shareholding - Replacement
17th Dec 20253:42 pmRNSDirector/PDMR Shareholding
17th Dec 202512:08 pmRNSDirector/PDMR Shareholding
15th Dec 20259:00 amRNSDirector/PDMR Shareholding
11th Dec 20258:52 amRNSDirector/PDMR Shareholding
5th Dec 20259:30 amRNSShare purchase by incoming Director (incoming CEO)
4th Dec 20259:06 amRNSFinancial Calendar Update
2nd Dec 20257:00 amRNSPreliminary Results
1st Dec 202510:49 amRNSBlock listing Interim Review
28th Nov 20259:27 amRNSTotal Voting Rights
20th Nov 20259:05 amRNSAdditional Listing
7th Nov 202510:39 amRNSHolding(s) in Company
31st Oct 20258:58 amRNSTotal Voting Rights
21st Oct 20257:30 amRNSCEO Succession update
3rd Oct 202511:36 amRNSHolding(s) in Company
3rd Oct 20259:03 amRNSHolding(s) in Company
30th Sep 20259:54 amRNSTotal Voting Rights
29th Aug 202510:16 amRNSTotal Voting Rights
31st Jul 20259:14 amRNSTotal Voting Rights
9th Jul 20251:02 pmRNSHolding(s) in Company
8th Jul 20253:33 pmRNSDirector/PDMR Shareholding
8th Jul 20257:00 amRNSDirectorate change: CEO succession
8th Jul 20257:00 amRNSQ3 Trading Update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.